Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-20

Clinical Trial Update: Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases [NA]

View source ↗

Summary

This completed clinical trial evaluated blood-brain barrier disruption using MR-guided focused ultrasound in HER2-positive breast cancer patients with brain met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: InSightec | Conditions: Breast Cancer, Brain Metastases | NA | Status: COMPLETED